Showing results (51-60 of 74) with videos related to
Sort By:
Pageof 8
Anti-Cancer Drugs|April 20, 2004
Development and characterization of two human tumor sublines expressing high-grade resistance to the cyanoguanidine CHS 828Joachim Gullbo, Henrik Lövborg, Sumeer Dhar, et al.Parasites & Vectors|July 12, 2014
Spotted fever Rickettsia species in Hyalomma and Ixodes ticks infesting migratory birds in the European Mediterranean areaKatarina Wallménius, Christos Barboutis, Thord Fransson, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 21, 2020
Vasculitis due to Candidatus Neoehrlichia mikurensis: A Cohort Study of 40 Swedish PatientsLinnea Höper, Elisabet Skoog, Martin Stenson, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 28, 2018
Serological reactivity to Anaplasma phagocytophilum in neoehrlichiosis patientsLinda Wass, Anna Grankvist, Mattias Mattsson, et al.Leukemia Research|August 4, 2004
Elevated levels of soluble CD44 are associated with advanced disease and in vitro proliferation of neoplastic lymphocytes in B-cell chronic lymphocytic leukaemiaWolfgang Eisterer, Oliver Bechter, Ola Söderberg, et al.European Journal of Haematology|November 4, 2004
VH gene mutation status and cellular drug resistance in chronic lymphocytic leukaemiaAnna Aleskog, Gerard Tobin, Anna Laurell, et al.Blood|July 28, 2005
Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse modelEline Menu, Helena Jernberg-Wiklund, Thomas Stromberg, et al.Respiratory Medicine|July 24, 2007
Bronchoalveolar matrix metalloproteinase 9 relates to restrictive lung function impairment in systemic sclerosisGrethe Neumann Andersen, Kenneth Nilsson, Jamshid Pourazar, et al.BMC Cancer|July 31, 2012
Stat1 activation attenuates IL-6 induced Stat3 activity but does not alter apoptosis sensitivity in multiple myelomaLina Y Dimberg, Anna Dimberg, Karolina Ivarsson, et al.Oncotarget|January 5, 2017
EZH2 inhibition in multiple myeloma downregulates myeloma associated oncogenes and upregulates microRNAs with potential tumor suppressor functionsMohammad Alzrigat, Alba Atienza Párraga, Prasoon Agarwal, et al.Pageof 8